Gynesonics Announces Key Executive Appointments to Further Accelerate and Expand Adoption of the Sonata Treatment
March 19, 2024 10:00 ET
|
Gynesonics
Gynesonics announces key executive appointments to further accelerate and expand adoption of the Sonata Treatment.
Gynesonics Announces New Category 1 CPT Code for its Sonata Transcervical RF Ablation Procedure Used to Treat Uterine Fibroids
January 02, 2024 11:13 ET
|
Gynesonics
Gynesonics Announces New Category 1 CPT Code for its Sonata Transcervical RF Ablation Procedure Used to Treat Uterine Fibroids
Gynesonics Announces $67M Financing to Expand Commercialization of Sonata® Procedure
November 02, 2023 09:41 ET
|
Gynesonics
Gynesonics Announces $67M Financing to Expand Commercialization of Sonata® Procedure
adyn Launches First Test Designed to Prevent Birth Control Side Effects
May 23, 2022 13:00 ET
|
Adyn, Inc.
SEATTLE, May 23, 2022 (GLOBE NEWSWIRE) -- adyn, the first to create a test designed to prevent birth control side effects, announced today the official launch of its flagship product, The Birth...
Fogarty Innovation Graduate Raydiant Oximetry Raises $5 Million in Oversubscribed Series A2 Financing Round to Support Clinical Study
November 02, 2021 12:00 ET
|
Fogarty Innovation
MOUNTAIN VIEW, Calif. and SAN RAMON, Calif., Nov. 02, 2021 (GLOBE NEWSWIRE) -- Fogarty Innovation, a nonprofit educational incubator for medical technology companies, announced today that its...
Evofem, Inc. Appoints Louis Villalba as Chief Business Officer
February 20, 2015 09:10 ET
|
Evofem
SAN DIEGO, Feb. 20, 2015 (GLOBE NEWSWIRE) -- Evofem, Inc. announces that Louis Villalba has been named Chief Business Officer (CBO), effective immediately. Mr. Villalba comes to Evofem with years of...